Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Ann Surg. 2021 Jun 16;276(6):e876–e885. doi: 10.1097/SLA.0000000000004993

Figure 3. The EMP stratifies cancer prognosis in multiple independent clinical cohorts in patients with PDAC.

Figure 3.

(A, C) Kaplan-Meier plot showing RFS between high- and low-risk groups estimated by the 6-exo-miRNA EMP in the training (A) and (C) validation cohorts. (B, D) Forest plots showing hazard ratios of clinicopathological variables and panel risk score status in uni- and multivariate cox proportional analyses of RFS in the training (B) and (D) validation cohorts.